N/A
Completed N=52
Feasibility Study to Test Clinical Efficacy of Low Energy AC Magnetic Field to Treat Major Depression
Major Depressive Disorder (MDD)
Source: ClinicalTrials.gov NCT01683019 ↗
Enrolled (actual)
52
Serious AEs
0.0%
Results posted
May 2014
Primary outcomePrimary: Percent Change in Hamilton Depression Rating Scale (HAMD-17) at Baseline and the End of Week 4 of Treatment. — -53.8; -53.1; -24.2 % change in HAM-D score
Summary
This feasibility study investigates effects of EEG-based low frequency, low emission magnetic cortical stimulation in comparison to a sham treatment in subjects with moderate to severe depressive disorder.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Percent Change in Hamilton Depression Rating Scale (HAMD-17) at Baseline and the End of Week 4 of Treatment. |
-53.8; -53.1; -24.2 | — |
Eligibility Criteria
Inclusion Criteria
- 18 years of age or older
- Diagnosis of MDD with HAMD-17 greater than or equal to 17
- On a stable dose of existing medication or no medication for 1 month or longer prior to the study
Exclusion Criteria
- Diagnosed with another primary Axis I illness
- Recent history of or current substance abuse
- Clinically significant medical illness, including any thyroid disorders
- Known pregnancy and/or lactation, or intent to become pregnant during the study
Data sourced from ClinicalTrials.gov (NCT01683019). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.